Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Integrative pathway analysis of metabolic signature in bladder cancer - a linkage to the Cancer Genome Atlas Project and prediction of survival.

von Rundstedt FC, Rajapakshe K, Ma J, Arnold J, Gohlke J, Putluri V, Krishnapuram R, Piyarathna DB, Lotan Y, Gödde D, Roth S, Störkel S, Levitt JM, Michailidis G, Sreekumar A, Lerner SP, Coarfa C, Putluri N.

J Urol. 2016 Jan 21. pii: S0022-5347(16)00072-0. doi: 10.1016/j.juro.2016.01.039. [Epub ahead of print]

2.

Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma.

Thomas AL, Coarfa C, Qian J, Wilkerson JJ, Rajapakshe K, Krett NL, Gunaratne PH, Rosen ST.

Nucl Recept Signal. 2015 Dec 22;13:e006. doi: 10.1621/nrs.13006. eCollection 2015.

3.

MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.

Zhang S, Wei JS, Li SQ, Badgett TC, Song YK, Agarwal S, Coarfa C, Tolman C, Hurd L, Liao H, He J, Wen X, Liu Z, Thiele CJ, Westermann F, Asgharzadeh S, Seeger RC, Maris JM, Guidry Auvil JM, Smith MA, Kolaczyk ED, Shohet J, Khan J.

Cancer Lett. 2016 Feb 28;371(2):214-24. doi: 10.1016/j.canlet.2015.11.045. Epub 2015 Dec 10.

PMID:
26683771
4.

Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer.

Holdman XB, Welte T, Rajapakshe K, Pond A, Coarfa C, Mo Q, Huang S, Hilsenbeck SG, Edwards DP, Zhang X, Rosen JM.

Breast Cancer Res. 2015 Nov 18;17:141. doi: 10.1186/s13058-015-0649-1.

5.

CpG methylation differences between neurons and glia are highly conserved from mouse to human.

Kessler NJ, Van Baak TE, Baker MS, Laritsky E, Coarfa C, Waterland RA.

Hum Mol Genet. 2016 Jan 15;25(2):223-32. doi: 10.1093/hmg/ddv459. Epub 2015 Nov 12.

PMID:
26566671
6.

Deciphering hepatocellular responses to metabolic and oncogenic stress.

Marcelo KL, Lin F, Rajapakshe K, Dean A, Gonzales N, Coarfa C, Means AR, Goldie LC, York B.

J Biol Methods. 2015;2(3). pii: e28. Epub 2015 Oct 8.

7.

Aberrant MUC1-TRIM46-KRTCAP2 Chimeric RNAs in High-Grade Serous Ovarian Carcinoma.

Kannan K, Kordestani GK, Galagoda A, Coarfa C, Yen L.

Cancers (Basel). 2015 Oct 19;7(4):2083-93. doi: 10.3390/cancers7040878.

8.

SRC-2 orchestrates polygenic inputs for fine-tuning glucose homeostasis.

Fleet T, Zhang B, Lin F, Zhu B, Dasgupta S, Stashi E, Tackett B, Thevananther S, Rajapakshe KI, Gonzales N, Dean A, Mao J, Timchenko N, Malovannaya A, Qin J, Coarfa C, DeMayo F, Dacso CC, Foulds CE, O'Malley BW, York B.

Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):E6068-77. doi: 10.1073/pnas.1519073112. Epub 2015 Oct 20.

PMID:
26487680
9.

Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically Relevant lncRNAs in Breast Cancer.

Jonsson P, Coarfa C, Mesmar F, Raz T, Rajapakshe K, Thompson JF, Gunaratne PH, Williams C.

Mol Endocrinol. 2015 Nov;29(11):1634-45. doi: 10.1210/me.2015-1153. Epub 2015 Oct 1.

PMID:
26426411
10.

Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.

Shafi AA, Putluri V, Arnold JM, Tsouko E, Maity S, Roberts JM, Coarfa C, Frigo DE, Putluri N, Sreekumar A, Weigel NL.

Oncotarget. 2015 Oct 13;6(31):31997-2012. doi: 10.18632/oncotarget.5585.

11.

Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.

Coarfa C, Fiskus W, Eedunuri VK, Rajapakshe K, Foley C, Chew SA, Shah SS, Geng C, Shou J, Mohamed JS, O'Malley BW, Mitsiades N.

Oncogene. 2015 Sep 14. doi: 10.1038/onc.2015.295. [Epub ahead of print]

PMID:
26364608
12.

Long Noncoding RNAs as Targets and Regulators of Nuclear Receptors.

Foulds CE, Panigrahi AK, Coarfa C, Lanz RB, O'Malley BW.

Curr Top Microbiol Immunol. 2015 Sep 12. [Epub ahead of print]

PMID:
26362934
13.

Identification of a Novel Coregulator, SH3YL1, That Interacts With the Androgen Receptor N-Terminus.

Blessing AM, Ganesan S, Rajapakshe K, Ying Sung Y, Reddy Bollu L, Shi Y, Cheung E, Coarfa C, Chang JT, McDonnell DP, Frigo DE.

Mol Endocrinol. 2015 Oct;29(10):1426-39. doi: 10.1210/me.2015-1079. Epub 2015 Aug 25.

PMID:
26305679
14.

Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage.

Chang CH, Zhang M, Rajapakshe K, Coarfa C, Edwards D, Huang S, Rosen JM.

Stem Cell Reports. 2015 Sep 8;5(3):378-91. doi: 10.1016/j.stemcr.2015.07.009. Epub 2015 Aug 20.

15.

Synergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinib.

Sun B, Shah B, Fiskus W, Qi J, Rajapakshe K, Coarfa C, Li L, Devaraj SG, Sharma S, Zhang L, Wang ML, Saenz DT, Krieger S, Bradner JE, Bhalla KN.

Blood. 2015 Sep 24;126(13):1565-74. doi: 10.1182/blood-2015-04-639542. Epub 2015 Aug 7.

16.

miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.

Eedunuri VK, Rajapakshe K, Fiskus W, Geng C, Chew SA, Foley C, Shah SS, Shou J, Mohamed JS, Coarfa C, O'Malley BW, Mitsiades N.

Mol Endocrinol. 2015 Aug;29(8):1170-83. doi: 10.1210/me.2015-1080. Epub 2015 Jun 12.

PMID:
26066330
17.

Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environment.

Silver MJ, Kessler NJ, Hennig BJ, Dominguez-Salas P, Laritsky E, Baker MS, Coarfa C, Hernandez-Vargas H, Castelino JM, Routledge MN, Gong YY, Herceg Z, Lee YS, Lee K, Moore SE, Fulford AJ, Prentice AM, Waterland RA.

Genome Biol. 2015 Jun 11;16:118. doi: 10.1186/s13059-015-0660-y.

18.

Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling.

Bhardwaj A, Ganesan N, Tachibana K, Rajapakshe K, Albarracin CT, Gunaratne PH, Coarfa C, Bedrosian I.

PLoS One. 2015 May 22;10(5):e0127678. doi: 10.1371/journal.pone.0127678. eCollection 2015.

19.

The camKK2/camKIV relay is an essential regulator of hepatic cancer.

Lin F, Marcelo KL, Rajapakshe K, Coarfa C, Dean A, Wilganowski N, Robinson H, Sevick E, Bissig KD, Goldie LC, Means AR, York B.

Hepatology. 2015 Aug;62(2):505-20. doi: 10.1002/hep.27832. Epub 2015 May 9.

20.

Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma.

Kannan K, Coarfa C, Chao PW, Luo L, Wang Y, Brinegar AE, Hawkins SM, Milosavljevic A, Matzuk MM, Yen L.

Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):E1272-7. doi: 10.1073/pnas.1501735112. Epub 2015 Mar 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk